GK

Gagan Kumar Singh

Active Director Director DIN 11452341
DIN 11452341 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Gagan Kumar Singh

Data last updated:

Gagan Kumar Singh is a Director at Hara Life Sciences Private Limited (since 2025).

DIN 11452341
Primary Designation Director
First Appointment 26 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hara Life Sciences Private Limited U46497UP2025PTC239819
Director26 Dec 20252025Active

Board colleagues of Gagan Kumar Singh

NameDINCompanyDesignation
Sanjay Kumar Tripathi11452342Hara Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hara Life Sciences Private Limited
Premium access

Shareholding and investment profile for Gagan Kumar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gagan Kumar Singh

Gagan Kumar Singh currently holds 1 directorship: Hara Life Sciences Private Limited (Director, since 26 Dec 2025).

Gagan Kumar Singh was first appointed on 26 Dec 2025 as Director at Hara Life Sciences Private Limited.

The current boards of Gagan Kumar Singh's companies include Sanjay Kumar Tripathi (Hara Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available